MAYNF (Mayne Pharma Group) OCF Yield %: 10.37 (As of Jun. 29, 2026) — 111% Above Median


MAYNF Mayne Pharma Group Ltd MAYNF
43 GF Score
Price $1.65
GF Value $3.41
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mayne Pharma Group OCF Yield %?

Mayne Pharma Group MAYNF 43 OCF Yield % is 10.37 as of Jun. 29, 2026, which is 111% above its 10-year median of 4.92. GuruFocus rates MAYNF with a GF Score™ of 43/100 and a GF Value™ of $3.41 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Mayne Pharma Group ranks better than 64.1% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Mayne Pharma Group's Trailing 12-Month Cash Flow from Operations is $14.0 Mil, and Market Cap is $144.1 Mil. Therefore, Mayne Pharma Group's OCF Yield % for today is 10.37%.

The historical rank and industry rank for Mayne Pharma Group's OCF Yield % or its related term are showing as below:

MAYNF' s OCF Yield % Range Over the Past 10 Years
Min: -17.36   Med: 4.92   Max: 30.11
Current: 10.37


During the past 13 years, the highest OCF Yield % of Mayne Pharma Group was 30.11%. The lowest was -17.36%. And the median was 4.92%.

MAYNF's OCF Yield % is ranked better than
64.1% of 117 companies
in the Medical Distribution industry
Industry Median: 5.97 vs MAYNF: 10.37

Mayne Pharma Group's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Mayne Pharma Group OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Mayne Pharma Group OCF Yield % Related Terms


Mayne Pharma Group OCF Yield % Historical Data

* Premium members only.

The historical data trend for Mayne Pharma Group's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mayne Pharma Group OCF Yield % Chart

Mayne Pharma Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.28 -1.84 -13.37 -4.17 4.20

Mayne Pharma Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.13 7.31 -7.28 14.68 -6.99

MAYNF vs MCK, CAH, COR: OCF Yield % Comparison

For the Medical Distribution subindustry, Mayne Pharma Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayne Pharma Group OCF Yield % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Mayne Pharma Group's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's OCF Yield % falls into.


MAYNF
43GF Score
Mayne Pharma Group Ltd MAYNF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mayne Pharma Group OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Mayne Pharma Group's OCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=11.373 / 270.5735538
=4.20%

Mayne Pharma Group's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-5.882 * 2 / 168.17922
=-6.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 10.37 mean?
Mayne Pharma Group (MAYNF) has a OCF Yield % of 10.37 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mayne Pharma Group and its competitors. This is 111% above median its historical median of 4.92. According to the industry distribution chart, Mayne Pharma Group ranks #42 out of 117 companies in the Medical Distribution industry, placing it in the top 35.9%.
Is Mayne Pharma Group's OCF Yield % too high?
Mayne Pharma Group's current OCF Yield % of 10.37 is 111% above median its 10-year median of 4.92. The Medical Distribution industry median OCF Yield % is 5.97. Mayne Pharma Group's value of 10.37 is 73.7% above this industry median. Based on the distribution chart, Mayne Pharma Group ranks #42 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Mayne Pharma Group has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's OCF Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Mayne Pharma Group ranks #42 out of 117 companies for OCF Yield %. This puts Mayne Pharma Group in the upper half of its industry. The industry median OCF Yield % is 5.97. Mayne Pharma Group's value of 10.37 is 73.7% above this benchmark. While the company's 10-year median is 4.92 vs. the industry median of 5.97, Mayne Pharma Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.97, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mayne Pharma Group's current OCF Yield % of 10.37 is 73.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mayne Pharma Group and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mayne Pharma Group's current OCF Yield % is 10.37, which is 111% above median its own 10-year median of 4.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.41, compared to a current price of $1.65 — trading 51.6% below its estimated fair value. The current OCF Yield % is 10.37, which is 111% above median its 10-year median of 4.92 and 73.7% above the Medical Distribution industry median of 5.97. Mayne Pharma Group's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current OCF Yield % is 10.37 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayne Pharma Group (MAYNF) Overvalued in 2026?

Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued. The current stock price of $1.65 is trading 51.6% below its estimated GF Value™ of $3.41. GuruFocus considers Mayne Pharma Group to be Possible Value Trap.

Key valuation signals for MAYNF:

  • OCF Yield %: 10.37 (111% above median its 10-year median of 4.92)
  • GF Value™: $3.41 vs. price of $1.65 (51.6% below fair value)
  • GF Score™: 43/100 with 3 warning signs
  • Industry Position: 73.7% above the Medical Distribution median (#42 of 117)

No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mayne Pharma Group Business Description

Other Exchanges MYX:Australia
Address 1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
43GF Score

Get the complete analysis for MAYNF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.65
Price
$3.41
GF Value